Welcome to LookChem.com Sign In|Join Free

CAS

  • or

155474-43-4

Post Buying Request

155474-43-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

155474-43-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 155474-43-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,4,7 and 4 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 155474-43:
(8*1)+(7*5)+(6*5)+(5*4)+(4*7)+(3*4)+(2*4)+(1*3)=144
144 % 10 = 4
So 155474-43-4 is a valid CAS Registry Number.

155474-43-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name [6-(aziridin-1-yl)-5,8-dihydroxy-4,7-dimethyl-2,3-dihydro-1H-pyrrolo[1,2-a]indol-3-yl] acetate

1.2 Other means of identification

Product number -
Other names 1H-Pyrrolo(1,2-a)indole-1,5,8-triol,7-(1-aziridinyl)-2,3-dihydro-6,9-dimethyl-,1-acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:155474-43-4 SDS

155474-43-4Downstream Products

155474-43-4Relevant articles and documents

A Comparison of the Cytotoxic and Physical Properties of Aziridinyl Quinone Derivatives Based on the Pyrrolobenzimidazole and Pyrroloindole Ring Systems

Boruah, Romesh,Skibo, Edward B.

, p. 1625 - 1631 (1994)

The cytotoxicity and physical properties of the pyrrolobenzimidazole (PBI) and pyrroloindole (PI) aziridinyl quinones were compared in order to assess the influence of the benzimidazole ring on antitumor activity and DNA reductive alkylation.Our studies show that the PI system possesses none of the cytotoxicity of the PBI systems.Unlike the PBIs, the PI system does not reductively alkylate DNA.Apparently, the benzimidazole ring favors reductive alkylation due to its electron deficient character compared to indole.In addition, the benzimidazole ringmay provide the hydrogen bonding interactions required for the interaction with DNA.Our findings resulted in the elucidation of a PBI pharmacophore.Inspection of the literature revealed another drug sharing the PBI pharmacophore, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione (EO9), which remarkably has cytotoxic properties similar to those of the PBIs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 155474-43-4